Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDPD1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | SPCS2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
mRNA | NDST1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
mRNA | ALAS1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
mRNA | CLN8 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
mRNA | LRRC10B | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
mRNA | FNTB | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
mRNA | LHPP | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
mRNA | ZNF451 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | ATP5G1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |